Table 3.

Models of Mean Differences and Prevalence Ratio Estimates Comparing SMARTT vs. NHANES for Each Metabolic Outcome^*

Model	Adjusted Mean Difference (95% CI)	p-value	Adjusted Prevalence Ratio (95% CI)	p-value
Systolic BP z-score	0.64 (0.52, 0.75)	<0.01	3.34 (2.48, 4.50)	<0.01
Diastolic BP z-score	0.72 (0.61, 0.83)	<0.01	2.04 (1.18, 3.52)	0.01
TC	−5.49 (−8.98, −1.99)	<0.01	0.67 (0.44, 1.01)	0.06
HDL	−0.41 (−1.66, 0.85)	0.52	1.27 (0.85, 1.88)	0.25
TG	−2.14 (−12.12, 7.85)	0.67	1.00 (0.40, 2.49)	1.00
LDL	−1.60 (−8.90, 5.71)	0.67	0.98 (0.38, 2.54)	0.96
Log HOMA-IR	−0.37 (−0.52, −0.21)	<0.01	0.67 (0.54, 0.85)^	<0.01

^*All models adjusted for age, body mass index Z-score, sex, and non-Hispanic Black race/ethnicity.

^{^}Outcome is insulin resistance defined as HOMA-IR >4.0

BP=Blood Pressure; CI=Confidence Interval; HDL=High-Density Lipoprotein Cholesterol; HOMA-IR=Homeostatic Model Assessment-Insulin Resistance; LDL=Low-Density Lipoprotein Cholesterol; TC=Total Cholesterol; TG=Triglycerides